These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 20234303)

  • 21. Reproducibility of the STARD checklist: an instrument to assess the quality of reporting of diagnostic accuracy studies.
    Smidt N; Rutjes AW; van der Windt DA; Ostelo RW; Bossuyt PM; Reitsma JB; Bouter LM; de Vet HC
    BMC Med Res Methodol; 2006 Mar; 6():12. PubMed ID: 16539705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficiency of clinical trial designs for predictive biomarker validation.
    Young KY; Laird A; Zhou XH
    Clin Trials; 2010 Oct; 7(5):557-66. PubMed ID: 20571132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A guide to interpretation of studies investigating subgroups of responders to physical therapy interventions.
    Hancock M; Herbert RD; Maher CG
    Phys Ther; 2009 Jul; 89(7):698-704. PubMed ID: 19465372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers of sepsis.
    Marshall JC; Reinhart K;
    Crit Care Med; 2009 Jul; 37(7):2290-8. PubMed ID: 19487943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The designs of exploratory biomarker study].
    Gosho M; Nagashima K; Sato Y
    Nihon Rinsho; 2012 May; 70(5):874-9. PubMed ID: 22620016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methodologic issues in randomized controlled trials of surgical interventions.
    Devereaux PJ; McKee MD; Yusuf S
    Clin Orthop Relat Res; 2003 Aug; (413):25-32. PubMed ID: 12897593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reporting of randomized controlled trials in Hodgkin lymphoma in biomedical journals.
    Kober T; Trelle S; Engert A
    J Natl Cancer Inst; 2006 May; 98(9):620-5. PubMed ID: 16670387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of biomarkers in population studies: from exposure to susceptibility and to prediction of cancer.
    Au WW
    Int J Hyg Environ Health; 2007 May; 210(3-4):239-46. PubMed ID: 17174154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Handling the limit of detection by extrapolation.
    Longford NT
    Stat Med; 2012 Nov; 31(26):3133-46. PubMed ID: 22532151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An urn based covariate adjusted response adaptive allocation design.
    Bandyopadhyay U; Bhattacharya R
    Stat Methods Med Res; 2012 Apr; 21(2):135-48. PubMed ID: 22287603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can a treatment be licenced on the basis of post-treatment predictive biomarkers?
    Stone A; Schmitt N
    Pharm Stat; 2014; 13(4):214-21. PubMed ID: 24809935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study design: statistical and methodologic considerations.
    Rubenfeld GD
    Respir Care; 1995 Sep; 40(9):980-6. PubMed ID: 10152244
    [No Abstract]   [Full Text] [Related]  

  • 33. On the design and analysis of randomized clinical trials with multiple endpoints.
    Tang DI; Geller NL; Pocock SJ
    Biometrics; 1993 Mar; 49(1):23-30. PubMed ID: 8513104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Quality of methodology and reporting of randomized controlled trials of acupuncture for obesity].
    Liu XM; Zhang MM; Du L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):192-4. PubMed ID: 15171560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel profile biomarker diagnosis for mass spectral proteomics.
    Han H
    Pac Symp Biocomput; 2014; ():340-51. PubMed ID: 24297560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Balancing between hope and hype in biomarker research].
    Bossuyt PM
    Ned Tijdschr Geneeskd; 2011; 155(35):A3859. PubMed ID: 21902852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling and Prediction in Neurological Disorders: The Biostatistical Perspective.
    Copetti M; Fontana A; Pellegrini F
    Front Neurol Neurosci; 2016; 39():50-9. PubMed ID: 27462982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recognizing the problem of delayed entry in time-to-event studies: Better late than never for clinical neuroscientists.
    Betensky RA; Mandel M
    Ann Neurol; 2015 Dec; 78(6):839-44. PubMed ID: 26452746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pragmatic statistical issues in biological research: Introduction to special series.
    Danziger RS; Berbaum ML
    J Mol Cell Cardiol; 2019 Aug; 133():211-213. PubMed ID: 29588139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Biomarkers in Critical Care and Perioperative Medicine: A Clinician’s Overview of Traditional Statistical Methods and Machine Learning Algorithms.
    Soussi S; Collins GS; Jüni P; Mebazaa A; Gayat E; Le Manach Y
    Anesthesiology; 2021 Jan; 134(1):15-25. PubMed ID: 33216849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.